Suchergebnisse - "Lerner, Seth P"

PubPharm (479)

1

Infigratinib Versus Placebo for Patients with High-risk Resected Urothelial Cancer Bearing an FGFR3 Genomic Alteration : Results from the PROOF302 Phase 3 Trial

enthalten in: European urology | 2024

von Pal, S. | Grivas, P. | Gupta, S. | +19

2

Three- and Seven-month Prostate-specific Antigen Levels as Prognostic Markers for Overall Survival in Metastatic Hormone-sensitive Prostate Cancer : Results from SWOG S1216, a Phase 3 Randomized Trial of Androgen Deprivation Plus Orteronel or Bicalutamide

enthalten in: European urology oncology | 2024

von Parikh, M. | Tangen, C. | Hussain, M. | +19

3

Multiomics profiling of urothelial carcinoma in situ reveals CIS-specific gene signature and immune characteristics

enthalten in: iScience | 2024

von Anurag, M. | Strandgaard, T. | Kim, S. | +9

4

The IL6/JAK/STAT3 signaling axis is a therapeutic vulnerability in SMARCB1-deficient bladder cancer

enthalten in: Nature communications | 2024

von Amara, C. | Kami Reddy, K. | Yuntao, Y. | +21

5

Association of Molecular Subtypes with Pathologic Response, PFS, and OS in a Phase II Study of COXEN with Neoadjuvant Chemotherapy for Muscle-invasive Bladder Cancer

enthalten in: Clinical cancer research : an official journal of the American Association for Cancer Research | 2024

von Lerner, S. | McConkey, D. | Tangen, C. | +14

6

Phase 2 Trial of Atezolizumab in Bacillus Calmette-Guérin-unresponsive High-risk Non-muscle-invasive Bladder Cancer : SWOG S1605

enthalten in: European urology | 2023

von Black, P. | Tangen, C. | Singh, P. | +12

7

Definitions, End Points, and Clinical Trial Designs for Bladder Cancer : Recommendations From the Society for Immunotherapy of Cancer and the International Bladder Cancer Group

enthalten in: Journal of clinical oncology : official journal of the American Society of Clinical Oncology | 2023

von Kamat, A. | Apolo, A. | Babjuk, M. | +21

8

Contemporary Role of Lymph Node Dissection in Genitourinary Cancers : Where Are We in 2023?

enthalten in: European urology oncology | 2023

von Myers, A. | Briganti, A. | Leibovich, B. | +9

9

Cell-free DNA Methylation as a Predictive Biomarker of Response to Neoadjuvant Chemotherapy for Patients with Muscle-invasive Bladder Cancer in SWOG S1314

enthalten in: European urology oncology | 2023

von Lu, Y. | Plets, M. | Morrison, G. | +13

10

Bacillus Calmette-Guérin vaccination as defense against SARS-CoV-2 (BADAS) : a randomized controlled trial to protect healthcare workers in the USA by enhanced trained immune responses

enthalten in: Trials | 2023

von DiNardo, A. | Arditi, M. | Kamat, A. | +25

1
2
3
4
5
6
7
8
9
10
11
Nächster »
[48]